Vaxart, Inc. Earnings Per Share Diluted

• Vaxart, Inc. showed an increase of +121.2% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2011 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $0.08 (loss) per share | Q2 2011: $0.11 (loss) per share | Q4 2011: $0.31 (loss) per share | Q1 2012: $0.09 (loss) per share | Q3 2012: $0.32 (loss) per share | Q4 2012: $0.16 per share | Q1 2013: $0.01 per share | Q3 2013: $0.14 (loss) per share | Q4 2013: $0.00 per share | Q1 2014: $0.09 per share | Q3 2014: $0.20 (loss) per share | Q4 2014: $0.19 per share | Q1 2015: $0.03 per share | Q3 2015: $0.17 (loss) per share | Q4 2015: $0.17 (loss) per share | Q1 2016: $0.14 (loss) per share | Q3 2016: $0.26 (loss) per share | Q1 2017: $25.84 (loss) per share | Q1 2018: $0.49 per share | Q1 2019: $0.18 (loss) per share.
• Over the full 5 years of available data (2011 to 2025), Vaxart, Inc.'s Earnings Per Share Diluted has grown by 106.3%.
• Historical annual values: Fiscal year 2025: $0.07 per share | Fiscal year 2024: $0.33 (loss) per share | Fiscal year 2013: $0.31 (loss) per share | Fiscal year 2012: $0.85 (loss) per share | Fiscal year 2011: $1.12 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026